Pharmacological modulation of circadian rhythms: A new drug target in psychotherapeutics

Expert Opinion on Therapeutic Targets

Volumn 8, Issue 1, 2004, Pages 25-38

  Sprouse, Jeffrey ^a  

^a PFIZER INC   (United States)

Author keywords

Biological clock; Circadian rhythms; Kinases; Neuropeptides; Serotonin; Suprachiasmatic nucleus (SCN)

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; CASEIN KINASE I; CLOZAPINE; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESULERGINE; MONOAMINE DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; OSEMOZOTAN; PHOSPHOTRANSFERASE; PSYCHOTROPIC AGENT; RITANSERIN; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 5A RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; UNINDEXED DRUG;

ADAPTATION; BEHAVIOR; BIOLOGICAL RHYTHM; BREAST CANCER; CHRONOBIOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; COLON CANCER; DRUG MEGADOSE; DRUG RESEARCH; DRUG TARGETING; ENVIRONMENT; HUMAN; INFORMATION PROCESSING; MALADJUSTMENT; MENTAL DISEASE; NONHUMAN; OSCILLATION; PHYSIOLOGY; PSYCHOTHERAPY; REGULATORY MECHANISM; REVIEW; SOMATOSENSORY SYSTEM;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE VASOPRESSIN; CASEIN KINASE IDELTA; CASEIN KINASE IEPSILON; CIRCADIAN RHYTHM; DRUG DESIGN; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; LIGHT; MELATONIN; MICE; MODELS, BIOLOGICAL; MOOD DISORDERS; NEURAL PATHWAYS; NEUROPEPTIDES; PSYCHOTROPIC DRUGS; RATS; RECEPTORS, SEROTONIN; SEROTONIN; SLEEP DISORDERS, INTRINSIC; SUPRACHIASMATIC NUCLEUS;

EID: 1242352528     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.8.1.25     Document Type: Review

References (146)

1. RAJARATNAM SM, ARENDT J: Health in a 24-h society. Lancet (2001) 358:999-1005.
2. DUNCAN WC: Circadian rhythms and the pharmacology of affective illness. Pharmacol. Ther. (1996) 71:253-312.
3. BUNNEY WE, BUNNEY BG: Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology (2000) 22:335-345.
4. RUSAK B, ZUCKER I: Neural regulation of circadian rhythms. Physiol. Rev. (1979) 59:449-526.
5. TUREK FW: Circadian neural rhythms in mammals. Annu. Rev. Physiol. (1986) 47:49-64.
6. MOGA MM, MOORE RY: Organization of neural inputs to the suprachiasmatic nucleus in the rat. J. Comp. Neurol. (1997) 389:508-534.
7. MOORE RV, SPEH JC, LEAK RK: Suprachiasmatic nucleus organization. Cell Tissue Res. (2002) 309:89-98.
8. PROSSER RA: Serotonergic actions and interactions on the SCN circadian pacemaker: in vitro investigations. Biol. Rhythm Res. (2000) 3:315-339.
9. HASTINGS MH, DUFFIELD GE, SMITH EJ, MYWOOD ES, EBLING FJ: Entrainment of the circadian system of mammals by nonphotic cues. Chronobiol. Int. (1998) 15:425-445.
10. MILLER JD, MORIN LP, SCHWARTZ WJ, MOORE RY: New insights into the mammalian circadian clock. Sleep (1996) 19:641-667.
11. MEYER-BERNSTEIN EL, MORIN LP: Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. (1996) 16:2097-2111.
12. MORIN LP: Serotonin and the regulation of mammalian circadian rhythmicity. Ann. Med. (1999) 31:12-33.
13. CARD JP, MOORE RY. Organization of lateral geniculate-hypothalamic connections in the rat. J. Comp. Neurol. (1989) 284:135-147.
14. MORIN LP, BLANCHARD J, MOORE RY: Intergeniculate leaflet and suprachiasmatic nucleus organization and connections in the golden hamster. Vis. Neurosci. (1992) 8:219-230.
15. CZEISLER CA, DUFFY JF, SHANAHAN TL et al.: Stability, precision, and near 24-hour period of the human circadian pacemaker. Science (1999) 284:2177-2181.
16. WEHR TA, WIRZ-JUSTICE A, GOODWIN FK, DUNCAN W, GILLIN JC: Phase advance of the circadian sleep - wake cycle as an antidepressant. Science (1979) 206:710-713.
17. WEHR TA, SACK D, ROSENTHAL N, DUNCAN W, GILLIN JC: Circadian rhythm disturbances in manic-depressive illness. Fed. Proc. (1983) 42:2809-2814.
18. BENCA RM, OBERMEYER WH, THISTED RA, GILLIN JC: Sleep and psychiatric disorders. A meta-analysis. Arch. Gen. Psychiatry (1992) 49:651-668.
19. WEHR TA, MUSCETTOLA G, GOODWIN FK: Urinary 3-methoxy-4-hydroxyphenylglycol circadian rhythm. Early timing (phase advance) in manic-depressives compared with normal subjects. Arch. Gen. Psychiatry (1980) 37:257-263.
20. WEHR TA, WIRZ-JUSTICE A: Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatry (1982) 15:31-39.
21. GILLIN JC, DUNCAN W, PETTIGREW BL, FRANKEL F, SNYDER F: Successful separation of depressed, normal and insomniac subjects by sleep EEG data. Arch. Gen. Psychiatry (1979) 36:85-90.
22. SACK DA, NURNBERGER J, ROSENTHAL NE, ASHBURN E, WEHR TA: Potentiation of antidepressant medications by phase advance of the sleep - wake cycle. Am. J Psychiatry (1985) 142:606-608.
23. WIRZ-JUSTICE A, VAN DEN HOOFDAKKER R: Sleep deprivation in depression: what do we know, where do we go? Biol. Psychiatry (1999) 46:445-453.
24. BICAKOVA-ROCHER A, GORCEIX A, REINBERG A, ASHKENAZI II, TICHER A: Temperature rhythm of patients with major affective disorders: reduced circadian period length. Chronobiol. Int. (1996) 13:47-57.
25. WEHR TA, SACK DA, DUNCAN WC, MENDELSON WB, ROSENTHAL NE, GILLIN JC: Sleep and circadian rhythms in affective patients isolated from external time cues. Psychiatry Res. (1985) 15:327-339.
26. KOORENGEVEL KM, BEERSMA DG, GORDIJN MC, DEN BOER JA, VAN DEN HOOFDAKKER RH: Body temperature and mood variations during forced desynchronization in winter depression: a preliminary report. Biol. Psychiatry (2000) 47:355-358.
27. WIRZ-JUSTICE A, CAJOCHEN C, NUSSBAUM P: A schizophrenic patient with an arrhythmic circadian rest - activity cycle. Psychiatry Res. (1997) 73:83-90.
28. OHASHI Y, OKAMOTO N, UCHIDA K, IYO M, MORI N, MORITA Y: Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer's type. Biol. Psychiatry (1999) 45:1646-1652.
29. CERMAKIAN N, BOIVIN D: A molecular perspective of human circadian disorders. Brain Res. Rev. (2003) 42:204-220.
30. MONK TH: What can the chronobiologist do to help the shift worker? J. Biol. Rhythms (2000) 15:86-94.
31. JONES CR, CAMPBELL SS, ZONE SE et al.: Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat. Neurosci. (1999) 5:1062-1065
32. VAN ESSEVELDT LE, HEHMAN MN, BOER GJ: The suprachiasmatic nucleus and the circadian timing system revisited. Brain Res. Rev. (2000) 33:34-77.
33. MOORE RY, SPEH JC: GABA is the principle neurotransmitter of the circadian system. Neurosci. Lett. (1993) 150:112-116.
34. SHINOHARA K, HONMA S, KATSUNO Y, ABE H, HONMA K: Two distinct oscillators in the rat suprachiasmatic nucleus in vitro. Proc. Natl. Acad. Sci. USA (1995) 92:7396-7400.
35. WELSH DK, LOGOTHETIS DE, MEISTER M, REPPERT SM: Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron (1995) 14:697-706.
36. LIU C, WEAVER DR, STROGATZ SH, REPPERT AM: Cellular construction of a circadian clock: period determination in the suprachiasmatic nuclei. Cell (1997) 91:855-860.
37. QUINTERO JE, KUHLMAN SJ, MCMAHON DG: The biological clock nucleus: a multiphasic oscillator network regulated by light. J. Neurosci. (2003) 23:8070-8076.
38. HONMA S, SHIRAKAWA W, NAKAMURA W, HONMA K: Synaptic communication of cellular oscillations in the rat suprachiasmatic neurons. Neurosci. Lett. (2000) 294:113-116.
39. SHINOHARA K, HIRUMA H, FUNABASHI T, KIMURA F: GABAergic modulation of gap junction communication in slice cultures of the rat suprachiasmatic nucleus. Neuroscience (2000) 96:591-596.
40. SHIRAKAWA T, HONMA S, HONMA K: Multiple oscillators in the suprachiasmatic nucleus. Chronobiol. Int. (2001) 18:371-387.
41. SILVER R, LESAUTER J, TRESCO PA, LEHMAN MN: A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature (1996) 382:810-813.
42. 2 receptor confers suprachiasmatic nuclei cellular rhythmicity and responsiveness to vasoactive intestinal polypeptide in vitro. Eur. J. Neurosci. (2003) 17:197-204.
43. (2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell (2002) 109:497-508.
44. KONOPKA RJ, BENZER S: Clock mutants of Drosophila melanogaster. Proc. Natl. Acad. Sci. USA (1971) 68:2112-2116.
45. FELDMAN JF, HOYLE MN: Isolation of circadian clock mutants of Neurospora crassa. Genetics (1973) 75:605-613.
46. GEKAKIS N, STAKNIS D, NGUYEN HB et al.: Role of the CLOCK protein in the mammalian circadian mechanism. Science (1998) 280:1564-1569.
47. TRAVNICKOVA-BENDOVA Z, CERMAKIAN N, REPPERT SM, SASSONE-CORSI P: Bimodal regulation of mPeriod promoters by CREB-dependent signalling and CLOCK/BMAL1 activity. Proc. Natl. Acad. Sci. USA (2002) 99:7728-7733.
48. YAMAGUCHI S, MITSUI S, MIYAKE S et al.: The 5′ upstream region of mPer1 gene contains two promotors and is responsible for circadian oscillation. Curr. Biol. (2000) 10:873-876.
49. GRIFFIN EA, STAKNIS D, WEITZ CJ: Light-independent role of CRY1 and CRY2 in the mammalian circadian clock. Science (1999) 286:768-771.
50. KUME K, ZYLKA MJ, SRIAM S et al.: mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell (1999) 98:193-205.
51. ONISHI H, YAMAGUCHI S, YAGITA K et al.: Rev-erbα gene expression in the mouse brain with special emphasis on its circadian profiles in the suprachiasmatic nucleus. J. Neurosci. Res. (2002) 68:551-557.
52. PREITNER N, DAMIOLA F, LOPEZ-MOLINA L et al.: The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell (2002) 110:251-260.
53. UEDA HR, CHEN W, ADACHI A et al.: A transcription factor response element for gene expression during circadian night. Nature (2002) 418:534-539.
54. SHEARMAN LP, SRIAM S, WEAVER DR et al.: Interacting molecular loops in the mammalian circadian clock. Science (2000) 288:1013-1019.
55. CERMAKIAN N, MONACO L, PANDO MP, DIERICH A, SASSONE-CORSI P: Altered behavioural rhythms and clock gene expression in mice with a targeted mutation in the Period1 gene. EMBO J. (2001) 20:3967-3974.
56. LOWREY PL, SHIMIMURA K, ANTOCH MP et al.: Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science (2000) 288:483-492.
57. VITATERNA MH, KING DP, CHANG AM et al.: Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behaviour. Science (1994) 264:719-725.
58. JIN X, SHEARMAN LP, WEAVER DR, ZYLKA MJ, DEVRIES GJ, REPPERT SM: A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell (1999) 96:57-68.
59. RIPPERGER JA, SHEARMAN LP, REPPERT SM, SCHIBBLER U: CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. (2000) 14:679-689.
60. LEE C, ETCHEGARAY JP, CAGAMPANG FR, LOUDON AS, REPPERT SM: Posttranslational mechanisms regulate the mammalian circadian clock. Cell (2001) 107:855-867.
61. VIELHABER E, EIDE E, RIVERS A, GAO ZH, VIRSHUP DM: Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase I ε. Mol. Cell. Biol. (2000) 20:4888-4899.
62. YAGITA K, TAMANINI F, YASUDA M, HOEIJMAKERS JH, VAN DER HORST GT, OKAMURA H: Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein. EMBO J. (2002) 21:1301-1314.
63. EIDE EJ, VIELHABER EL, HINZ WA, VIRSHUP DM: The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase I ε. J. Biol. Chem. (2002) 277:17248-17254.
64. KEESLER GA, CAMACHO F, GUO Y, VIRSHUP D, MONDADORI C, YAO Z: Phosphorylation and destabilization of human period 1 clock protein by human casein kinase I ε. Neuroreport (2000) 119:1220-1223.
65. AKASHI M, TSUCHIYA Y, YOSHINO T, NISHIDA E: Control of intracellular dynamics of mammalian period proteins by casein kinase I ε (CKIε) and CKIδ in cultured cells. Mol. Cell. Biol. (2002) 22:1693-1703.
66. DUNLAP JC: Molecular basis for circadian clocks. Cell (1999) 290:271-290.
67. EIDE EJ, VIELHABER EL, HINZ WA, VIRSHUP DM: The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase Iε. J. Biol. Chem. (2002) 277:17248-17254.
68. DING Y, DALE T: Wnt signal transduction: kinase cogs in a nano-machine? Trends Biochem. Sci. (2002) 27:327-329.
69. MARTINEK S, INONOG S, MANOUKIAN AS, YOUNG MW: A role for the segment polarity gene shaggy/ GSK-3 in the Drosophila circadian clock. Cell (2001) 105:769-779.
70. MOORE RY, LENN NJ: A retinohypothalamic projection in the rat. J. Comp. Neurol. (1972) 146:1-14.
71. BERSON DM, DUNN FA, TAKAO M: Phototransduction by retinal ganglion cells that set the circadian clock. Science (2002) 295:1070-1073.
72. HATTAR S, LIAO HW, TAKAO M, BERSON DM, YAU KM: Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science (2002) 295:1065-1070.
73. PANDA S, SATO TK, CASTRUCCI AM et al.: Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science (2002) 298:2213-2216.
74. RUBY NF, BRENNAN TJ, XIE X et al.: Role of melanopsin in circadian responses to light. Science (2002) 298:2211-2213.
75. SELBY CP, THOMPSON C, SCHMITZ TM, VAN GELDER RN: Functional redundancy of cryptochromes and classical photoreceptors for nonvisual ocular photoreceptors in mice. Proc. Natl. Acad. Sci. USA (2000) 97:14697-14702.
76. CERMAKIAN N, SASSONE-CORSI P: Environmental stimulus perception and control of circadian clocks. Curr. Opin. Neurobiol. (2002) 12:359-365.
77. EBLING FJ: The role of glutamate in the photic regulation of the suprachiasmatic nucleus. Prog. Neurobiol. (1996) 50:109-132.
78. KORNHAUSER JM, GINTY DD, GREENBERG ME, MAYO KE, TAKAHASHI JS: Light entrainment and activation of signal transduction pathways in the SCN. Prog. Brain Res. (1996) 111:133-145.
79. MINTZ EM, MARVEL CL, GILLESPIE CF, PRICE KM, ALBERS HE: Activation of NMDA receptors in the suprachiasmatic nucleus produces light-like phase shifts of the circadian clock in vivo. J. Neurosci. (1999) 19:5124-5130.
80. DING JM, CHEN D, WEBER ET, FAIMAN LE, REA MA, GILLETTE MU: Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science (1994) 266:1713-1717.
81. PROSSER RA: Glutamate blocks serotonergic phase advances of the mammalian circadian pacemaker through AMPA and NMDA receptors. J. Neurosci. (2001) 21:7815-7822.
82. HANNIBAL J, DING JM, CHEN D, FAHRENKRUG J, LARSEN PJ, GILLETTE MU: Pituitary adenylate cyclase-activating peptide (PACAP) in the retinohypothalamic tract: a potential daytime regulator of the biological clock. J. Neurosci. (1997) 17:2637-2644.
83. HARRINGTON ME, HOQUE S, HALL A, GOLOMBEK D, BIELLO S: Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J Neurosci. (1999) 19:6637-6642.
84. SHIBATA S, TSUNEYOSHI A, HAMADA T, TOMINAGA K, WATANABE S: Effect of substance P on circadian rhythms of firing activity and the 2-dexoyglucose uptake in the rat suprachiasmatic nucleus in vitro. Brain Res. (1992) 597:257-263.
85. SHIRAKAWA T, MOORE RY: Responses of rat suprachiasmatic nucleus neurons to substance P and glutamate in vitro. Brain Res. (1994) 642:213-220.
86. 1 receptor antagonist affects the circadian regulation of locomotor activity in golden hamsters. Brain Res. (1998) 800:32-39.
87. CHALLET E, DUGOVIC C, TUREK FW, VAN REETH O: The selective neurokinin 1 receptor antagonist R116301 modulates photic responses of the hamster circadian system. Neuropharmacology (2001) 40:408-415.
88. MORIN LP: The circadian visual system. Brain Res. Rev. (1994) 67:102-127.
89. RUSAK B, MEIJER JH, HARRINGTON ME: Hamster circadian rhythms are phase-shifted by electrical stimulation of the geniculo-hypothalamic tract. Brain Res. (1989) 493:283-291.
90. BIELLO SM, GOLOMBEK A, HARRINGTON ME: Neuropeptide Y and glutamate block each other's phase shifts in the suprachiasmatic nucleus in vitro. Neuroscience (1997) 77:1049-1057.
91. 2 receptor. Neuroreport (1996) 7:1249-1252.
92. BIELLO SM, JANIK D, MROSOVSKY NM: Neuropeptide Y and behaviorally induced phase shifts. Neuroscience (1994) 62:273-279.
93. HARRINGTON ME, NANCE DM, RUSACK B: Double-labeling of neuropeptide Y-immunoreactive neurons which project from the geniculate to the suprachiasmatic nuclei. Brain Res. (1987) 410:275-282.
94. MORIN LP, BLANCHARD J, MOORE RY: Intergeniculate leaflet and suprachiasmatic nucleus organization and connections in the golden hamster. Vis. Neurosci. (1992) 8:219-230.
95. PROSSER RA: Neuropeptide Y blocks serotonergic phase shifts of the suprachiasmatic circadian clock in vitro. Brain Res. (1998) 808:31-41.
96. BIELLO SM: Enhanced photic phase shifting after treatment with antiserum to neuropeptide Y. Brain Res. (1995) 673:25-29.
97. BIELLO SM, MROVOSKY NM: Blocking the phase-shifting effect of neuropeptide Y with light. Proc. R. Soc. Lond. B. Biol. Sci. (1995) 259:179-187.
98. WEBER ET, REA MA: Neuropeptide Y blocks light-induced phase advances but not delays of the circadian activity rhythm in hamsters. Neurosci. Lett. (1997) 231:159-162.
99. 5 receptor mediates the blockade of 'photic-like' NMDA-induced phase shifts in the golden hamster. J. Neurosci. (2001) 21:5367-5373.
100. 5 receptor agonist. Neuroscience (2003) 119:611-618.
101. MOORE RY, HALARIS AE, JONES BE: Serotonin neurons of the midbrain raphe: ascending projections. J. Comp. Neurol. (1978) 180:417-438.
102. VAN DER KAR LD, LORENS SA: Differential serotonergic innervation of hypothalamic nuclei and other forebrain regions by dorsal and median midbrain raphe nuclei. Brain Res. (1979) 162:45-54.
103. MEYER-BERNSTEIN EL, MORIN LP: Differential serotonergic innervation of the suprachiasmatic nucleus and the intergeniculate leaflet and its role in circadian rhythm modulation. J. Neurosci. (1996) 16:2097-2111.
104. GLASS JD, NINARDO LA, EHLEN JC: Dorsal raphe nuclear stimulation of SCN serotonin release and circadian phase-setting. Brain Res. (2000) 859:224-232.
105. 1A receptor agonist, on the photic entrainment of the circadian activity rhythm in hamsters. Br. J. Pharmacol. (1998) 125:1281-1287.
106. 7) implicated in the regulation of mammalian circadian rhythms. Neuron (1993) 11:449-458.
107. 7 receptors. J. Biol. Rhythms (2001) 16:25-38.
108. (7) agonist: phase shifts of the circadian biological clock through increases in cAMP production. Neuropharmacology (2004) 46:52-62.
109. REA MA, PICKARD GE: Serotonergic modulation of photic entrainment in the syrian hamster. Biol. Rhythm Res. (2000) 31:284-314.
110. 1A/1B double-knockout mice. J. Pharmacol. Exp. Ther. (2002) 302:240-248.
111. 7 receptors in the suprachiasmatic nucleus. J. Neurosci. (2001) 21:5351-5357.
112. WEBER ET, GANNON RL, REA MA: Local administration of serotonin agonists blocks light-induced phase advances of the circadian activity rhythm in the hamster. J. Biol. Rhythms (1998) 13:209-218.
113. MINTZ EM, GILLESPIE CF, MARVEL CL, HUHMAN KL, ALBERS HE: Serotonergic regulation of circadian rhythms in syrian hamsters. Neuroscience (1997) 79:563-569.
114. 7 receptors in the rodent suprachiasmatic nucleus. J. Biol. Rhythms (2001) 16:19-24.
115. 7 receptor agonist, on locomotor activity in golden hamster in constant darkness. Neurosci. Lett. (1996) 210:1-4.
116. 1A/2/7 agonists in vivo: surprisingly little. J. Biol. Rhythms (2003) 18:145-158.
117. PROSSER RA: Serotonin phase-shifts the mouse suprachiasmatic circadian clock in vitro. Brain Res. (2003) 966:110-115.
118. 1B receptor agonists inhibit light-induced phase shifts of behavioural circadian rhythms and expression of the intermediate-early gene c-fos in the suprachiasmatic nucleus. J. Neurosci. (1996) 16:8208-8220.
119. 1B receptor-mediated presynaptic inhibition of retinal input to the suprachiasmatic nucleus. J. Neurosci. (1999) 19:4034-4045.
120. 5A receptors? Abstr. Soc. Neurosci. (2002).
121. 5A receptors in discrete regions of the circadian timing system in the syrian hamster. Brain Res. (2000) 869:175-185.
122. 5A receptor-like immunoreactivity in the rat brain. Brain Res. (2000) 867:131-142.
123. 7 receptors in the mouse suprachiasmatic nucleus. J. Comp. Neurol. (2001) 432:381-388.
124. YANNIELLI PC, CADEIRAS M, GREGORETTI L, KARGIEMAN L, CARDINALI DP, GOLOMBEK DA: Effects of clomipramine administration on syrian hamster circadian system and behaviour. Biol. Rhythm Res. (2000) 31:391-415.
125. LAM RW, ZIS AO, GREWAL A, DELGADO PL, CHARNEY DS, KRYSTAL JH: Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch. Gen. Psychiatry (1996) 53:41-44.
126. DELAGRANGE P, ATKINSON J, BOUTIN JA et al.: Therapeutic perspectives for melatonin agonists and antagonists. J. Neuroendocrinol. (2003) 15:442-448.
127. CAJOCHEN C, KRAUCHI K, WIRZ-JUSTICE A: Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol. (2003) 15:432-437.
128. MOORE RY, KLEIN DC: Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase. Brain Res. (1974) 71:17-33.
129. REPPERT SM, PERLOW MJ, UNGERLEIDER LG et al.: Effects of damage to the suprachiasmatic area of anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J. Neurosci. (1981) 1:1414-1425.
130. PAPP M, GRUCA P, BOYER PA, MOCAER E: Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology (2003) 28:694-703.
131. MILES A, PHILBRICK DR: Melatonin and psychiatry. Biol. Psychiatry (1988) 23:405-425.
132. ABRAHAMSON EE, LEAK RK, MOORE RY: The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport (2001) 22:350-356.
133. ASTON-JONES G, CHEN S, ZHU Y, OSHINSKY ML: A neural circuit for circadian regulation of arousal. Nat. Neurosci. (2001) 4:732-738.
134. BUIJS RM, LA FLEUR SE, WORTEL J et al.: The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J. Comp. Neurol. (2003) 464:36-48.
135. ZYLKA MJ, SHEARMAN LP, WEAVER DR, REPPERT SM: Three period homologs in mammals: differential light responses in the suprachiasmatic circadian clock and oscillating transcripts outside of brain. Neuron (1998) 20:1103-1110.
136. ONISHI K, SAKAMOTO K, OKADA T, NAGASE T, ISHIDA N: Antiphase circadian expression between BMAL1 and period homologue mRNA in the suprachiasmatic nucleus and peripheral tissues of rats. Biochem. Biophys. Res. Commun. (1998) 253:199-203.
137. TOSINI G, MENAKER M: Circadian rhythms in cultured mammalian retina. Science (1996) 272:419-421.
138. REICK M, GARCIA JA, DUDLEY C, MCKNIGHT SL: NPAS2: an analog of clock operative in mammalian forebrain. Science (2001) 293:506-509.
139. KALSBEEK A, VAN HEERIKHUIZE JJ, WORTEL J, BUIJS RM: A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist. J. Neurosci. (1996) 16:5555-5565.
140. KRAMER A, WANG FC, SNODGRASS P et al.: Regulation of daily locomotor activity and sleep by hypothalamic EGF receptor signalling. Science (2001) 294:2511-2515.
141. CHENG MY, BULLOCK CM, LI C et al.: Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature (2002) 417:405-410.
142. WAGNER S, CASTEL M, GAINER H, YAROM Y: GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature (1997) 387:598-603.
143. ELLIOTT KJ, WEBER ET, REA MA: Adenosine A1 receptors regulate the response of the hamster circadian clock to light. Eur. J. Pharmacol. (2001) 414:43-53.
144. JACOBS EH, YAMATODANI A, TIMMERMAN H: Is histamine the final neurotransmitter in the entrainment of circadian rhythms in mammals? Trends Pharmacol. Sci. (2000) 21:293-298.
145. PIGGINS HD, ANTLE M, RUSAK B: Neuropeptides phase shift the mammalian circadian pacemaker. J. Neurosci. (1995) 15:5612-5622.
146. PITTENDRIGH CS: Circadian systems: entrainment. In: Handbook of Behavioural Neurobiology (Vol. 4). Biological Rhythms Aschoff J (Ed.), Plenum Press, New York (1981):95-124.